ARK Fintech Innovation ETF vs Zimmer Biomet Holdings Inc — how do they compare? ARK Fintech Innovation ETF trades at $42.86, while Zimmer Biomet Holdings Inc trades at $97.27 (market cap $18.55B). The key difference: Zimmer Biomet Holdings Inc pays a 0.99% dividend while ARK Fintech Innovation ETF pays none, and Zimmer Biomet Holdings Inc is trading nearer its 52-week high, ARK Fintech Innovation ETF nearer its low. Which is the better fit depends on your goals.
| ARKF | ZBH | |
|---|---|---|
Sector | Sector/Thematic | Health |
52-Week High | $58.82 | $107.71 |
52-Week Low | $36.14 | $79.58 |
Market Cap | — | $18.55B |
Enterprise Value | — | $25.61B |
Dividend Yield | — | 0.99% |
Trailing returns across standard periods
ARKF is an actively managed ETF that invests in companies leading the way in fintech innovation. Key themes include mobile payments, digital wallets, blockchain technology, and frictionless funding platforms.
Read more on ARKF →Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly 70% of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, and related surgical products.
Read more on ZBH →